Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 69Carcinoma, Non-Small-Cell Lung 62Stomach Neoplasms 32Prostatic Neoplasms 21Nasopharyngeal Carcinoma 20Lung Neoplasms 20Squamous Cell Carcinoma of Head and Neck 11Esophageal Neoplasms 11Neoplasm Metastasis 8Head and Neck Neoplasms 7Inflammatory Breast Neoplasms 6Pancreatic Neoplasms 5Neoplasms 5HER2-positive Breast Cancer 5Adenocarcinoma 5Triple Negative Breast Neoplasms 4Ovarian Neoplasms 4NSCLC 4Carcinoma, Squamous Cell 4Sarcoma 3Nasopharyngeal Neoplasms 3Hypopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Ovarian Epithelial 3Breast Diseases 3Adenocarcinoma of Lung 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tongue Neoplasms 2Squamous Cell Lung Cancer 2

Interventions

Docetaxel 2apatinib 1Taxes 1S 1 (combination) 1Radiotherapy 1Paclitaxel 1Injections 1Drug Evaluation 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Gastric Adenocarcinoma × Docetaxel × Clear all
NCT05705635 2023-01-31

A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 2 Unknown
100 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT01283217 2013-06-04

Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer

Yonsei University

Phase 3 Unknown
166 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡